Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 Virus Infection”

10,132 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 10,132 results

Early research (Phase 1)Ended earlyNCT03891420
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19

Who this might be right for
COVID-19Yellow Fever
BioCryst Pharmaceuticals 24
Not applicableStudy completedNCT04647682
What this trial is testing

Physical Activity Program Implementation in Hospitalized Positive COVID-19 Older Adults

Who this might be right for
COVID-19 Infection
University Hospital, Toulouse 62
Not applicableUnknownNCT04836754
What this trial is testing

The Effect of Covid-19 on Breast Milk Microbiome and Its Bioactive Components

Who this might be right for
Covid19Human Milk
Aysu Yıldız Karaahmet 30
Not applicableStudy completedNCT04473105
What this trial is testing

Optimising Resource Allocation Via Prediction of Outcomes for Covid-19

Who this might be right for
COVID19
Nottingham University Hospitals NHS Trust 11,134
Large-scale testing (Phase 3)Study completedNCT04491994
What this trial is testing

Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression

Who this might be right for
Covid19Progression
UNICEF 540
Very early researchUnknownNCT05679466
What this trial is testing

An Investigator Initiated, Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Immunogenicity and Efficacy of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) in Adults Aged 18 Years and Older

Who this might be right for
Prevention of COVID-19 Caused by SARS-CoV-2
Yu Qin 3,300
Not applicableUnknownNCT04836351
What this trial is testing

Rehabilitation for Patients With Persistent Symptoms Post COVID-19

Who this might be right for
Covid19
Western Norway University of Applied Sciences 20
Not applicableStudy completedNCT05317962
What this trial is testing

COVID-19 Echo Study

Who this might be right for
Covid-19Cardiac Disease
London North West Healthcare NHS Trust 251
Not applicableUnknownNCT04896788
What this trial is testing

Monitoring of the Post-vaccination Immune Response to COVID-19 Among Hospital Staff

Who this might be right for
Hospital StaffVaccined Againt COVID-19
University Hospital, Clermont-Ferrand 300
Large-scale testing (Phase 3)UnknownNCT04604327
What this trial is testing

Comparison of Two Different Doses of Bemiparin in COVID-19

Who this might be right for
COVID-19
Clinica Universidad de Navarra, Universidad de Navarra 164
Not applicableStudy completedNCT04647305
What this trial is testing

Effectiveness and Adherence to Closed Face Shields to Prevent COVID-19 Transmission

Who this might be right for
SARS-CoV-2 Infection
University of Los Andes, Columbia 233
Not applicableStudy completedNCT04393805
What this trial is testing

Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto

Who this might be right for
COVID-19Hypercoagulability
Quovadis Associazione 744
Not applicableStudy completedNCT05977166
What this trial is testing

Hyperbaric on Pulmonary Functions in Post Covid -19 Patients.

Who this might be right for
Post COVID-19 Patients
Cairo University 72
Not applicableStudy completedNCT04345510
What this trial is testing

Testing for COVID-19 Infection in Asymptomatic Persons

Who this might be right for
COVID-19 Infection
German Cancer Research Center 500
Testing effectiveness (Phase 2)Ended earlyNCT04433546
What this trial is testing

Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).

Who this might be right for
Acute Respiratory Distress SyndromeCoronavirusHypoxic Respiratory Failure+15 more
PhaseBio Pharmaceuticals Inc. 54
Not applicableLooking for participantsNCT07278388
What this trial is testing

Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2

Who this might be right for
PASC Post Acute Sequelae of COVID 19Fatigue
Hugo W. Moser Research Institute at Kennedy Krieger, Inc. 200
Not applicableStudy completedNCT04670003
What this trial is testing

Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application

Who this might be right for
Covid19
Weprom 4,975
Not applicableStudy completedNCT04412369
What this trial is testing

Multi-modality Imaging & Immunophenotyping of COVID-19 Related Myocardial Injury

Who this might be right for
COVID19Cardiovascular Diseases
University of Cambridge 21
Not applicableUnknownNCT04924894
What this trial is testing

Determinants of Obtaining Covid Vaccination Among Health Care Workers

Who this might be right for
COVID-19 Vaccination
Assiut University 350
Testing effectiveness (Phase 2)UnknownNCT04404218
What this trial is testing

The Açaí Berry COVID-19 Anti-Inflammation Trial

Who this might be right for
COVID
University Health Network, Toronto 480
Load More Results